We present automated continuous evolution (ACE), a platform for the hands-free directed evolution of biomolecules. ACE pairs OrthoRep, a genetic system for continuous targeted mutagenesis of user-selected genes in vivo, with eVOLVER, a scalable and automated continuous culture device for precise, multi-parameter regulation of growth conditions. By implementing real-time feedback-controlled tuning of selection stringency with eVOLVER, genes of interest encoded on OrthoRep autonomously traversed multimutation adaptive pathways to reach desired functions, including drug resistance and improved enzyme activity. The durability, scalability, and speed of biomolecular evolution with ACE should be broadly applicable to protein engineering as well as prospective studies on how selection parameters and schedules shape adaptation.
mutagenesis with OrthoRep must be coupled with a functional selection that can be tuned over the course of a continuous evolution experiment. This tuning is necessary to precisely and efficiently guide populations to the desired evolutionary search depth. For example, evolution of novel functions requiring long mutational trajectories may demand frequent modification of selection conditions in order to maintain strong selection 4, 5, 8 , guide evolution through strategic intermediate functions 1, 5 , or impose periods of neutral drift or alternating selection to promote crossing of fitness valleys 9, 10 (Fig. 1c ). Yet, selection schedules cannot be determined a priori as the generation of beneficial mutations is a fundamentally stochastic process. Therefore, selection schedules should be adjusted dynamically based on how populations adapt, rendering manual implementation of continuous evolution experiments onerous. Previous continuous evolution campaigns approached the challenge of optimizing selection schedules by either limiting the number of parallel evolution experiments being carried out so that selection can be manually changed on the fly 1, 4 , or by setting a fixed but conservative selection schedule to buffer against variations in adaptation rate across a large numbers of replicate experiments 2 . However, even with conservative selection schedules, a proportion of replicates in high-throughput evolution studies went extinct when the rate of selection stringency increase outpaced the rate of adaption 2 . Enter eVOLVER. eVOLVER is a versatile continuous culture platform that enables multiparameter control of growth selection conditions across independent microbial cultures 11, 12 (Fig. 1b ). eVOLVER's flexible hardware and software permit development of "algorithmic selection routines" that apply selective pressures based on real-time monitoring and feedback from culture growth characteristics. Additionally, eVOLVER's robust framework ensures experimental durability over long timeframes, and its unique scalable design allows independent control over tens to hundreds of cultures. Combining
OrthoRep and eVOLVER should therefore enable continuous evolution with speed, depth, and scale.
Here we describe this pairing of OrthoRep with eVOLVER to achieve Automated Continuous Evolution (ACE) (Fig. 1c ). By implementing a closed-loop feedback routine that dynamically adjusts the strength of selection for a desired function in response to growth rate changes of yeast populations diversifying a GOI on OrthoRep, we demonstrate continuous evolution over extended periods of time without manual intervention. To illustrate the performance and utility of ACE, we describe its application in two model protein evolution experiments, one yielding drug-resistant Plasmodium falciparum dihydrofolate reductases (PfDHFRs) and the other yielding variants of the thermophilic HisA enzyme from Thermotoga maritima (TmHisA) that operate well in mesophilic yeast hosts.
To establish ACE, we first reconfigured eVOLVER Smart Sleeves 13 so that each culture vial receives two media inputs: (1) 'no selection' base media (e.g. media without drug or with the maximum concentration of nutrient in our cases) and (2) 'full selection' media (e.g. media with the maximum concentration of drug or without nutrient in our cases). As a result, using eVOLVER software calculations, selection strength can be dynamically tuned by altering the ratios of the two media inputs as cultures are diluted over time (Fig. 1b,c) . We then implemented a closed-loop control system that seeks to achieve and maintain a target culture growth rate by dynamically adjusting selection strength. Briefly, culture growth rate is continuously measured based on realtime recordings of optical density (OD), and a proportional-integral-derivative (PID) control algorithm 13 is used to determine the percentage of full selection media to add to the culture in order to minimize error between the actual growth rate and a target growth rate (or setpoint) (see Methods). Although simpler feedback algorithms have been previously used in microbial evolution experiments 14,15 , these resulted in growth rate oscillations or excessive overshooting in our experiments, frequently driving cultures to extinction ( Supplementary Fig. 1 ).
To validate ACE, we first repeated a continuous evolution experiment that we previously conducted using manual serial passaging. Specifically, we evolved Plasmodium falciparum dihydrofolate reductase (PfDHFR) to develop drug resistance to the antimalarial drug, pyrimethamine, by encoding PfDHFR on OrthoRep in a yeast strain that relies on PfDHFR activity for survival 2 (Fig. 2 ). We determined appropriate PID constants to tune the concentration of pyrimethamine ( Fig. 2b and Supplementary Fig. 2 ) and keep the measured growth rate of cells at a target growth rate ( Fig. 2a , setpoint = dashed black line). This program forced cells to continuously experience a strong selection pressure imposed by pyrimethamine, which resulted in the rapid evolution of PfDHFR resistance ( Fig. 2c ). We observed that after ~550 hours (~100 generations) of continuous hands-free operation of ACE, five out of six replicates adapted to 3 mM pyrimethamine, the highest concentration of pyrimethamine soluble in liquid media ( Fig. 2b and Supplementary Fig. 3 ). ACE maintained cultures near the target growth rate over the entire course of the experiment ( Fig. 2a,b ), demonstrating the effectiveness of the control loop. In contrast to the use of a fixed selection schedule 2 or simpler control algorithms for selection ( Supplementary Fig. 1 ) that resulted in occasional extinction caused by too-rapid increases in pyrimethamine concentration, all six ACE experiments reliably adapted to yield multi-mutation pyrimethamine-resistant PfDHFR variants. Validating our method, we found that populations converged on strong resistance mutations in PfDHFR -C50R, D54N, Y57H, C59R, C59Y, and S108N -as observed and characterized previously 2 (Fig. 2c ). Additionally, the monotonically increasing pyrimethamine concentrations we observed for most replicates (Fig. 2b ) are consistent with step-wise fixation of beneficial mutations expected for the evolution of PfDHFR resistance under strong selection 2, 16 . Finally, ACE demonstrated a substantial increase in speed over our previous evolution campaign performed by manual passaging; with ACE, culture growth rates in 5/6 vials stabilized at the maximum pyrimethamine concentration after ~550 hours, which is over 200 hours faster than for the manual evolution campaign done with serial passaging 2 . Collectively, these results validate the ACE system and highlight its ability to enable reliable and rapid continuous evolution of proteins.
We next applied ACE to evolve the thermophilic Thermotoga maritima HisA enzyme (TmHisA) to function in Saccharomyces cerevisiae at mesophilic temperatures. TmHisA, an ortholog of S. cerevisiae HIS6, catalyzes the isomerization of ProFAR to PRFAR in the biosynthesis of histidine. However, wild-type TmHisA does not effectively complement a his6 deletion in yeast when expressed from a medium-strength yeast promoter ( Fig. 3 ), likely due to the different temperature niches of S. cerevisiae and T. maritima (30˚C and 80˚C, respectively).
We reasoned that ACE could readily drive the evolution of TmHisA to function in yeast Dhis6 strains by selecting for growth in media lacking histidine. This evolution serves as a valuable test of the capabilities of ACE for at least two reasons. First, adapting enzymes from non-model thermophiles to function in model mesophiles is useful for industrial biotechnology whose infrastructure is designed around model organisms like yeast and bacteria. Second, in contrast to drug resistance in PfDHFR, which is driven by a small number of large effect mutations 3 , we reasoned that temperature adaptation of enzyme activity would involve a large number of small effect mutations, leading to a more complex fitness landscape. This would act as a demanding test of ACE requiring precise feedback-control to efficiently traverse adaptive paths.
We encoded TmHisA on OrthoRep in a Dhis6 strain and carried out ACE selection in four independent replicates for a total of 600 hours (~100 generations) ( Fig. 3 and Supplementary Fig.   4 ). At the beginning of the experiment, there was no detectable growth in the absence of histidine.
At the end of the experiment, all four replicates successfully adapted to media lacking histidine.
To confirm that TmHisA evolution was responsible for the observed adaptation, TmHisA variants were isolated from OrthoRep and characterized for their ability to complement a his6 deletion in fresh yeast strains. Indeed, the evolved TmHisA variants we sampled were able to support growth in media lacking histidine in contrast to wild-type TmHisA (Fig. 3c ). Consistent with a model of a more complex fitness landscape, growth rate traces for the four replicate cultures were noisier ( Fig.   3a ) than those of PfDHFR ( Fig. 2a ), full adaptation occurred only after a long period of neutral drift (hours ~100-500 in Fig. 3b ), and the sequences of independently evolved TmHisAs were diverse ( Fig. 3d and Supplementary Table 1 ). Nevertheless, ACE was able to autonomously adapt TmHisA in all four replicates within 120 fewer hours than manual passaging experiments (unpublished results). Sequencing of sampled clones revealed TmHisA variants harboring between 6 and 15 mutations ( Supplementary Table 1 ), again demonstrating the durability of ACE in carrying out long evolutionary searches to discover high-activity multi-mutation enzyme variants.
In summary, we have developed a fully automated, in vivo continuous evolution setup termed ACE that couples OrthoRep-driven continuous mutagenesis and eVOLVER-enabled programmable selection. We demonstrated the evolution of drug resistance in PfDHFR and mesophilic operation of TmHisA, showcasing the ability of ACE to individually control selection schedules in multi-replicate GOI evolution experiments based on real-time measures of adaptation.
The result is a system that offers unprecedented speed, depth, and scalability for conducting evolutionary campaigns to achieve ambitious protein functions. ACE paves the way for an array of complex evolution experiments that can advance both basic and applied protein and enzyme evolution. For example, eVOLVER can be used to program multidimensional selection gradients across OrthoRep experiments, test the effects of different population sizes (and beneficial mutation supply) on the outcomes of adaptation, or explore the relationship between timescales of drift and adaptation. Real-time feedback on growth metrics to adjust selection stringency can ensure that every evolving population is being constantly challenged or allowed to drift, which is especially relevant when evolving biomolecules with rugged fitness landscapes where predefined selection strategies are prone to driving populations to extinction or local fitness maxima. In the future, many other algorithmic selection routines may be implemented with ACE to more efficiently and intelligently navigate fitness landscapes. For example, machine learning algorithms can take the outcomes of replicate evolution experiments carried out under different selection schedules to train ACE selection programs themselves.
Finally, the automated, open-source nature of ACE is well-suited for integration with other opensource hardware and wetware tools to create larger automation pipelines. Overall, we foresee ACE as an enabling platform for rapid, deep, and scalable continuous GOI evolution for applied protein engineering and studying the fundamentals of protein evolution.
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Methods

Cloning
All plasmids used in this study are listed in Supplementary Table 2 . Plasmids were cloned using either restriction enzymes if compatible sites were available or using Gibson cloning 17 with 20-40 bps of overlap. Primers and gBlocks were ordered from IDT Technologies. Enzymes for PCR and cloning were purchased from NEB. Plasmids were cloned into either Top10 E. coli cells from Thermo Fisher or SS320 E. coli from Lucigen.
Yeast transformation and DNA extraction
All yeast strains used in this study are listed in Supplementary Table 3 . Yeast transformations were done with roughly 100 ng -1 µg of plasmid or donor DNA via the Gietz high-efficiency transformation method 18 . For integration of genes onto the orthogonal plasmid (pGKL1), cassettes were linearized with ScaI and subsequently transformed as described previously 2, 7 . Standard preparations of YPD and drop-out synthetic media were obtained from US Biological. When necessary, the following were supplemented at their respective concentrations: 5-FOA at 1 mg/mL, G418 at 400 µg/mL, and Nourseothricin at 200 µg/mL. Yeast DNA extraction of orthogonal plasmids were done as previously reported 2,7 .
eVOLVER feedback control configuration
ACE experiments were performed using the previously described eVOLVER continuous culture system 11 where B is the growth rate. Using the current and historical growth rate, a dilution parameter, ( ) was calculated as described below to dilute the morbidostat. The morbidostat algorithm and eVOLVER experimental code are written in Python and included in the supplemental files.
The efflux pump for each vessel is actuated whenever either of the influx pumps are triggered and stay ON for an additional 5 seconds. Therefore, the volume of the culture vessel is determined by the length of the efflux straw and estimated to be at 30 mL. The flow rate of each media input was individually calibrated for accurate metering of drug or nutrient into the culture.
Before each experiment, 40 mL borosilicate glass vessels (Chemglass), stir bars (Fisher), and fluidic straws were assembled and autoclaved. Fluidic lines were sterilized by flushing with 10% bleach and 70% ethanol before use. Culture vessel assemblies were connected to fluidic lines after sterilization and slotted into an eVOLVER Smart Sleeve for monitoring of OD and control of temperature and stir rate.
PID algorithm development and tuning
To control the rate of dilution, we used the following equation to determine the percentage of selection media to add:
( ) = -( ) + / 0 ( ) where -, / , 4 , and 5 , are empirically determined constant multipliers of proportional, integral, derivative, and offset terms, and ( ) is the difference between the actual growth rate and the target growth rate. To estimate -, / , 4 , and 5 , we used the the Ziegler-Nichols method 19 for initially tuning the parameters with the pre-evolution strain, ZZ-Y323. / and 4 were first set to zero andwas increased until regular oscillations in growth rate were observed ( Supplementary Fig. 2 ). This resulted in a -= 4.
Using the parameters obtained during the oscillation and the Ziegler-Nichols estimation: ) was reset at every instance the proportional error ( ( )) became negative, and the offset ( 5 ) was updated to equal ( ) at that time. This was done to allow the PID controller to be more sensitive to the integral error and to avoid the bias that would result from the initial conditions having minimal selection pressure.
PfDHFR evolution
eVOLVER was set to morbidostat mode with the PID settings described above, a target doubling Supplementary Fig. 3 ), so the experiment was stopped and cultures were frozen in glycerol stocks.
TmHisA evolution
eVOLVER was set to morbidostat mode with the PID settings described above, a target doubling Supplementary Fig. 4 ), so the experiment was stopped and cultures were frozen in glycerol stocks.
Bulk DNA sequencing and characterization
Final evolution timepoints of PfDHFR and TmHisA were regrown in SC-HW and SC-ULH media, respectively, from glycerol stocks. The orthogonal plasmids encoding evolved PfDHFR or
TmHisA were extracted from the bulk cultures as described above, PCR amplified, and sequenced via Sanger sequencing. Mutation frequencies were calculated from Sanger sequencing files with QSVanalyzer as previously described 2 . However, V1 from TmHisA evolution could not be revived from the glycerol stock due to a stocking mistake and was not included for bulk DNA sequencing.
TmHisA isolated mutant cloning
Final evolution time-points of TmHisA were streaked onto SC-ULH solid media. Individual colonies were regrown in SC-ULH media and the orthogonal plasmid DNA was extracted from the cultures as described above. The evolved TmHisA sequences were sequenced and cloned into a nuclear CEN6/ARS4 expression vector under control of the pRPL18B promoter and with the LEU2 selection marker. Since each colony can have different TmHisA mutants due to the multicopy nature of the orthogonal plasmid in OrthoRep, the cloned plasmids were sequenced again to determine the exact mutant of TmHisA being characterized. The resulting plasmids were transformed into ZZ-Y354, which lacks his6, for growth rate measurements.
TmHisA growth rate measurements
Yeast strains containing each TmHisA mutant, WT TmHisA, S. cerevisiae HIS6, or none of the above expressed from a nuclear plasmid were grown to saturation in SC-L and diluted 1:100 in SC-LH. Three 100 uL replicates of each strain were placed into a 96 well clear-bottom tray, sealed, and grown at 30 °C. Cultures were continuously shaken and OD600 was measured every 30 minutes automatically for 15 hours (Tecan Infinite M200 Pro) according to a previously described protocol 20 . A custom MATLAB script (growthassayV3.m), included in supplemental files, was used to calculate growth rates from raw OD600 data. The script carries out a logarithmic transformation of the OD600 data. The linear region of the transformed data as a function of time corresponds to log phase growth. A sliding window approach is used to find and fit this linear region in order to calculate the doubling time during log phase growth. This doubling time (T) is converted to the continuous growth rate plotted in Fig. 3c by the formula ln(2)/T.
Statistical analysis
Statistical analysis was done using GraphPad Prism and one-way ANOVA with multiple comparisons versus wild-type TmHisA and corrected for multiple comparisons. Results are reported at p < 0.05. Figure 1 . Sample evolution experiments in eVOLVER using the control algorithm derived from Toprak et al. 2013 15 . Briefly, this algorithm sampled OD at fixed intervals and if (1) the current OD is greater than a threshold and (2) if the current OD is greater than the previous OD, the growing cultures were diluted with the selection media. Otherwise, the culture would be diluted with the base media (a) An example of PfDHFR evolution using the Toprak et al. algorithm. ZZ-Y435 was inoculated into eVOLVER and grown as described in Methods except the control algorithm was as described in Toprak et al. 15 . The OD of the adapting culture (red) and the calculated concentration of pyrimethamine (blue) are shown. After the initial increase and subsequent decrease of pyrimethamine, no further growth is seen in 40 hours. (b) An example of TmHisA evolution using the Toprak et al. 15 algorithm. ZZ-Y323 was inoculated into eVOLVER and grown as described in Methods except for the control algorithm. The OD of the adapting culture (red) and the calculated concentration of histidine in the media (blue) are shown. The concentration of histidine is observed to oscillate during selection and is unable to successfully adapt. Supplementary Table 1 . TmHisA mutants characterized. Both nonsynonymous mutations (bold) and synonymous are noted. The order of these variants (top to bottom) corresponds to the order of the variants (left to right) in Figure 3c .
Supplementary
Name
Mutations from wt TmHisA N62N, E71G, L85F, R98R, F124L, K168K, K182R, E186E, S202S, V209A,  F226S  V1-3 G12E, E29K, V36M, H75Y, I185T, R224K  V1-4 F27F, I40T, G43G, E71G, F72L, L112L, V123V, D127D, A140T, E186E , V209A V1-6 E37G, E71G, F124L, L126L, E186E, S199P, V209A V2-1 A15V, E37G, E71R, D108D, F124L, L172L, E186E, V209A
V2-2
V4A, A15V, Y28H, E37G, E71G, S102G, A134V, V147V, D176Y, K182E, I183T, E186E, V209A, T213T, E228K V2-4 I18T, E71G, K181R, V209A, I221V V3-1 H2Q, A6A, E71G, F72L, V123V, V133A, E186E, E188E, V209A, E234G
V3-2
H2Q, A6A, D8D, N24S, E71G, F72L, V123V, V133A, E186E, E188E, V209A, E234G
V3-3 H2Q, A6A, V14V, E71G, F72L, V123V, V133A, I161V, E186E, E188E, V209A, E234G
V3-5 H2Q, A6A, E71G, F72L, I82V, V123V, V133A, G170D, E186E, E188E, V209A, E234G V4-1 V4A, F27S, V36M, E41E, R97R, S125S, M236T V4-2 E71G, F72L, V105A, V123V, I144T, E186E, S199A, V209A, G223R 
